SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from JOHNSON & JOHNSON (JNJ) (CIK 0000200406) (JNJ) — May 15, 2013

JOHNSON & JOHNSON (JNJ) (CIK 0000200406)
Date: May 15, 2013 · CIK: 0000200406 · Accession: 0000200406-13-000067

AI Filing Summary & Sentiment

File numbers found in text: 001-03215

Date
May 15, 2013
Author
/s/ Stephen J. Cosgrove
Form
CORRESP
Company
JOHNSON & JOHNSON (JNJ) (CIK 0000200406)

Letter

Via EDGAR Division of Corporation Finance Re: Johnson & Johnson Form 10-K for the Fiscal Year Ended December 30, 2012 Filed February 22, 2013 File No. 001-03215

Dear Mr. Rosenberg:

Johnson & Johnson is submitting this letter in response to the verbal comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”), communicated on May 14, 2013, with respect to Johnson & Johnson's Form 10-K filed with the Commission on February 22, 2013 for the fiscal year ended December 30, 2012 (the “Form 10-K”) (SEC File No. 001-03215).

Set forth below is the verbal comment followed by our response:

Verbal Comment:

1.

We note your response to prior comment 2. Please confirm that you will revise your disclosure in future filings to replace the reference to the purchase method with the acquisition method.

Response:

In response to the Staff's verbal comment, the Company will replace the reference to the purchase method with the acquisition method in future filings.

Verbal Comment:

2.

We note your response to prior comment 3. Please provide revised disclosure to be included in future periodic reports which includes the useful life information in your response, specifically the weighted asset life for each asset class (Customer Relationships and Patents and Technology) and how the weighted asset lives were determined.

Response:

In response to the Staff's verbal comment, the Company will provide the response to prior comment 3 filed with the Commission on April 23, 2013 as disclosure in future periodic reports.

As requested, we acknowledge that:

•

Johnson & Johnson is responsible for the adequacy and accuracy of the disclosure in the filing;

•

Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to this filing; and

•

Johnson & Johnson may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please do not hesitate to contact me at 732-524-3737 with any questions or comments you may have.

Sincerely,
/s/ Stephen J. Cosgrove

Show Raw Text
CORRESP
1
filename1.htm

		Verbal Comment - May 2013

Stephen J. Cosgrove

Vice President

Corporate Controller

 One Johnson & Johnson Plaza

New Brunswick, NJ 08933

May 15, 2013

Via EDGAR

Mr. Jim B. Rosenberg

Senior Assistant Chief Accountant

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Re:    Johnson & Johnson

Form 10-K for the Fiscal Year Ended December 30, 2012

Filed February 22, 2013

File No. 001-03215

Dear Mr. Rosenberg:

Johnson & Johnson is submitting this letter in response to the verbal comments of the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”), communicated on May 14, 2013, with respect to Johnson & Johnson's Form 10-K filed with the Commission on February 22, 2013 for the fiscal year ended December 30, 2012 (the “Form 10-K”) (SEC File No. 001-03215).

Set forth below is the verbal comment followed by our response:

Verbal Comment:

1.

 We note your response to prior comment 2.  Please confirm that you will revise your disclosure in future filings to replace the reference to the purchase method with the acquisition method.

Response:

In response to the Staff's verbal comment, the Company will replace the reference to the purchase method with the acquisition method in future filings.

Verbal Comment:

2.

 We note your response to prior comment 3.  Please provide revised disclosure to be included in future periodic reports which includes the useful life information in your response, specifically the weighted asset life for each asset class (Customer Relationships and Patents and Technology) and how the weighted asset lives were determined.

Response:

In response to the Staff's verbal comment, the Company will provide the response to prior comment 3 filed with the Commission on April 23, 2013 as disclosure in future periodic reports.

As requested, we acknowledge that:

•

 Johnson & Johnson is responsible for the adequacy and accuracy of the disclosure in the filing;

•

 Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to this filing; and

•

 Johnson & Johnson may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please do not hesitate to contact me at 732-524-3737 with any questions or comments you may have.

 Sincerely,

/s/ Stephen J. Cosgrove

Vice President

Corporate Controller

Chief Accounting Officer

cc: Dominic J. Caruso